4-Bromo-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 5g

(R)-2-(Methylamino)propanoic acid hydrochloride, 95.0%, 25g

1,2,4,5-Tetraethynylbenzene, 97%, 100mg

5-methyl-1,3,4-oxadiazole-2-thiol, 95.0%, 10g

2,5-Dibromo-p-xylene>98.0%(GC)25g

Filtres pour seringues Polytétrafluoroéthylène hydrophobe (PTFE), 0,22 µm, 13 mm, non stérile, 100 pièce(s)

Tert-butyl n-(5-amino-2,4-difluorophenyl)carbamate, 95%, 1g

ethyl 6-isopropyl-4-oxo-1,4-dihydroquinoline-3-carboxylate, 97%, 500mg

5-Chloropyrazine-2-carboxylic acid, 95.0%, 25g

(S)-5-(1-(2,3-Dimethylphenyl)ethyl)-1H-imidazole hydrochloride, 95.0%, 5mg

Benzyl (2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate, 96%, 1g

2-Amino-5-tert-butyl-1,3,4-thiadiazole, 97.0%, 5g

6-Bromo-2-chloro-3-nitropyridine, 95.0%, 25g